Agenda

January 30, 2026

7:00am            Breakfast, Exhibits, & Registration

8:00am            Welcome & Orientation

8:10am            Top 5 Breakthroughs from ASH 2025

  • Rafael Madero-Marroquin, MD

  • Alexandra Rojek, MD

  • Elijah Darnell, MD

  • Adam Stepanovic, MD

                        Moderated by: Gregory Roloff, MD

8:55am            Updates in Managing HM Pharmacologic Conditions
– Jennifer Collins, PharmD, BCOP

                        Moderated by: Kaitlin Kelly, PharmD

9:25am            Myeloma Session - Yi Lin, MD, PhD

9:55am            Case Study in Myeloma Panel: Bispecifics in Myeloma Therapy

  • Yi Lin, MD, PhD

  • Jennifer Cooperrider, MD

                       Moderated by:

10:35am          Break & Exhibits

11:05am          Gene Therapy & Non-Malignant Hematology & Sickle Cell

                        Moderated by: Satyajit Kosuri, MD

11:50am          Networking Lunches

1:00pm           Acute Lymphoblastic Leukemia in Adults: Emerging Innovations and Clinical Impact– Marlise Luskin, MD

1:50pm           Leukemia Panel

  • Marlise Luskin, MD

  • Gregory Roloff, MD

   Moderated by: Anand Patel, MD

2:30pm           Bispecific Toxicities Panel

  • Kaitlin Kelly, PharmD

  • Divya Khandekar, PharmD, BCOP

  • Danielle Murphy, PharmD

Moderated by: Jennifer Collins, PharmD, BCOP

3:00pm           Break & Exhibits

3:30pm           Lymphoma Session – Brad Khal, MD

4:00pm           Case Study in Lymphoma Panel: The Role of Bispecifics and CAR-T Therapies

  • Brad Kahl, MD

Moderated by: Justin Kline, MD

4:40pm            Top 10 Takeaways from Post-ASH

  • Rafael Madero-Marroquin, MD

  • Alexandra Rojek, MD

  • Elijah Darnell, MD

  • Gregory Roloff, MD

  • Adam Stepanovic, MD

Moderated by: Michael Bishop, MD

5:00pm           Thank you & Closing Remarks – Michael Bishop, MD

5:00pm           Reception

6:00pm           Adjourn